Compare Amylx Pharmaceuticals Inc (AMLX) vs CleanSpark Inc (CLSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs CleanSpark Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.71 (market cap $2.64B), while CleanSpark Inc trades at $12.13 (market cap $2.96B). The key difference: Amylx Pharmaceuticals Inc and CleanSpark Inc are close in size by market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, CleanSpark Inc nearer its low. Which is the better fit depends on your goals.
| AMLX | CLSK | |
|---|---|---|
Market Cap | $2.64B | $2.96B |
Sector | Health | Technology |
52-Week High | $24.19 | $23.20 |
52-Week Low | $7.82 | $8.18 |
Enterprise Value | $2.39B | $3.95B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
CleanSpark (CLSK) trades at $12.23, up 5.52% today but showing bearish technical signals with recent earnings misses. The company reported a Q3 2026 loss of $0.89 per share versus expectations of $0.47, continuing a trend of negative profitability despite securing a significant $6.6 billion AI data center lease. Revenue declined to $679 million in 2026 with a negative profit margin of -146.91%, though analyst consensus remains unanimously bullish with a $24.13 price target.
The stock presents a high-risk opportunity with strong institutional support but significant fundamental challenges. While the AI infrastructure pivot offers long-term potential, near-term execution risks and persistent losses require careful monitoring. The 100% buy rating from analysts suggests confidence in the strategic shift, but investors must weigh the substantial valuation premium against ongoing cash burn and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About CleanSpark Inc
CleanSpark is a leading Bitcoin mining company that operates high-density data centers. It focuses on using sustainable energy to power its mining fleet and provides digital infrastructure for the blockchain ecosystem.
Read more on CLSK →
